UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC

Annals of oncology, 2023-04, Vol.34 (4), p.377-388

2023

Volltextzugriff (PDF)

Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive locally advanced/metastatic NSCLC

Annals of oncology, 2019-04, Vol.30, p.i38-i38

2019

Volltextzugriff (PDF)

Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome

Japanese journal of clinical oncology, 2012-05, Vol.42 (5), p.420-426

2012

Volltextzugriff (PDF)

Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

British journal of cancer, 2014-04, Vol.110 (8), p.1968-1976

2014

Volltextzugriff (PDF)

3354 Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study

European journal of cancer (1990), 2015-09, Vol.51, p.S686-S687

2015

Volltextzugriff (PDF)

The Prognostic Factors and Results of Neoadjuvant Treatment Protocol in Extremity Soft Tissue Sarcomas: Single Institution Results

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S659-S659

2012

Volltextzugriff (PDF)

P2.22-02 Long-term Survival in Patients with Primitive Neuroectodermal Tumors of Thorax: Does Size Matter?

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S392-S393

2023

Volltextzugriff (PDF)

Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression

Journal of B.U. ON., 2010-10, Vol.15 (4), p.774

2010

Volltextzugriff (PDF)

2104 POSTER Role of FDG-PET/CT in the Evaluation of Bone Marrow Involvement of Solid Tumours

European journal of cancer (1990), 2011, Vol.47, p.S210-S210

2011

Volltextzugriff (PDF)

Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer

Journal of B.U. ON., 2013-04, Vol.18 (2), p.385-390

2013

Volltextzugriff (PDF)

EP1.18-23 Is Salvage Lung Resection Necessary After Definitive Chemoradiation Therapy for Stage IIIA(N2) Non-Small Cell Lung Cancer?

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S1104-S1105

2019

Volltextzugriff (PDF)

Determining predominating histologic component in malignant mixed müllerian tumors: is it worth it?

International journal of gynecological cancer, 2008-07, Vol.18 (4), p.809-812

2008

Volltextzugriff (PDF)

Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma

Medical oncology (Northwood, London, England), 2004-01, Vol.21 (1), p.67-72

2004

Volltextzugriff (PDF)

Devastating effects of chemotherapy: deafness and acute renal failure in a patient with epithelial ovarian cancer

International journal of gynecological cancer, 2006-02, Vol.16 (S1), p.394-396

2006

Volltextzugriff (PDF)

Metastatic primitive neuroectodermal tumor of the ovary in pregnancy

International journal of gynecological cancer, 2007-01, Vol.17 (1), p.266-269

2007

Volltextzugriff (PDF)

Determining predominating histologic component in malignant mixed mü llerian tumors: is it worth it?

International journal of gynecological cancer, 2008-07, Vol.18 (4), p.809-812

2008

Volltextzugriff (PDF)

Devastating effects of chemotherapy: deafness and acute renal failure in a patient with epithelial ovarian cancer

International journal of gynecological cancer, 2006-01, Vol.16 (Suppl 1), p.394-396

2006

Volltextzugriff (PDF)

Receptor Expression Discrepancy between Primary and Metastatic Breast Cancer Lesions

Oncology research and treatment, 2014, Vol.37 (11), p.622-626

2014

Volltextzugriff (PDF)

Safety and efficacy of transdermal fentanyl in patients with cancer pain: phase IV, Turkish oncology group trial

European journal of cancer care, 2007-01, Vol.16 (1), p.67-73

2007

Volltextzugriff (PDF)

9099 Is there any future of prophylactic cranial irradiation in adenocarcinoma of the lung?

European journal of cancer supplements, 2009, Vol.7 (2), p.534-534

2009

Volltextzugriff (PDF)

102OFinal analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive locally advanced/metastatic NSCLC

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Volltextzugriff (PDF)

Retraction Note: Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

British journal of cancer, 2014-06, Vol.110 (12), p.2996-2996

2014

Volltextzugriff (PDF)

PS1 Phase 3 KEYNOTE-042 Study: Pembrolizumab vs Platinum-Based Chemotherapy as 1l Therapy for Advanced NSCLC with a PD-L1 TPS ≥1

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.S152-S152

2018

Volltextzugriff (PDF)

P1.14-15 Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S558-S559

2019

Volltextzugriff (PDF)

Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

British journal of cancer, 2014-06, Vol.110 (12), p.2996-2996

2014

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(124)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC

Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive locally advanced/metastatic NSCLC

Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome

Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

3354 Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study

The Prognostic Factors and Results of Neoadjuvant Treatment Protocol in Extremity Soft Tissue Sarcomas: Single Institution Results

P2.22-02 Long-term Survival in Patients with Primitive Neuroectodermal Tumors of Thorax: Does Size Matter?

Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression

2104 POSTER Role of FDG-PET/CT in the Evaluation of Bone Marrow Involvement of Solid Tumours

Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer

EP1.18-23 Is Salvage Lung Resection Necessary After Definitive Chemoradiation Therapy for Stage IIIA(N2) Non-Small Cell Lung Cancer?

Determining predominating histologic component in malignant mixed müllerian tumors: is it worth it?

Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma

Devastating effects of chemotherapy: deafness and acute renal failure in a patient with epithelial ovarian cancer

Metastatic primitive neuroectodermal tumor of the ovary in pregnancy

Determining predominating histologic component in malignant mixed mü llerian tumors: is it worth it?

Devastating effects of chemotherapy: deafness and acute renal failure in a patient with epithelial ovarian cancer

Receptor Expression Discrepancy between Primary and Metastatic Breast Cancer Lesions

Safety and efficacy of transdermal fentanyl in patients with cancer pain: phase IV, Turkish oncology group trial

9099 Is there any future of prophylactic cranial irradiation in adenocarcinoma of the lung?

102OFinal analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1–positive locally advanced/metastatic NSCLC

Retraction Note: Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

PS1 Phase 3 KEYNOTE-042 Study: Pembrolizumab vs Platinum-Based Chemotherapy as 1l Therapy for Advanced NSCLC with a PD-L1 TPS ≥1

P1.14-15 Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey

Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

Suchergebnisse filtern